Literature DB >> 2496877

Methylprednisolone and Graves' ophthalmopathy.

P Dandona, C W Havard, A Mier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2496877      PMCID： PMC1836047          DOI： 10.1136/bmj.298.6676.830

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Increased serum pancreatic enzymes after treatment with methylprednisolone: possible evidence of subclinical pancreatitis.

Authors:  P Dandona; D Junglee; A Katrak; V Fonseca; C W Havard
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-06

2.  Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy.

Authors:  P Kendall-Taylor; A L Crombie; A M Stephenson; M Hardwick; K Hall
Journal:  BMJ       Date:  1988-12-17

3.  Beneficial effects of intensive plasma exchange followed by immunosuppressive therapy in severe Graves' ophthalmopathy.

Authors:  D Glinoer; J Etienne-Decerf; M Schrooyen; G Sand; P Hoyoux; P Mahieu; R Winand
Journal:  Acta Endocrinol (Copenh)       Date:  1986-01

4.  Successful treatment of exophthalmos and pretibial myxoedema with plasmapheresis.

Authors:  P Dandona; N J Marshall; S P Bidey; A Nathan; C W Havard
Journal:  Br Med J       Date:  1979-02-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.